You are here

Portage Biotech Inc.

Listing Exchange: 
CSE
Status: 
Halted Pending Fundamental Change
Industry: 
Life Sciences
Symbol: 
PBT.U
CSE Index: 
Currency: 

Portage is engaged in researching and developing pharmaceutical and biotech products through to clinical "proof of concept" with an initial focus on unmet clinical needs and orphan drugs. Following proof of concept, Portage will look to sell or license the products to large pharmaceutical companies for further development and commercialization.

You are here

Portage Biotech Inc. (PBT.U)

SEDAR Information

Company Info

Address
47 Avenue Road, Suite 200
Toronto, ON M5R 2G3
Canada
Phone
416-929-1806
Fax
416-929-6612
Email
ks@portagebiotech.com
Listing date
Monday, October 28, 2013

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
260,688,894
Reserved for Issuance: 
20,317,194

Company Officers

Dr. Declan Doogan, Chief Executive Officer and director
Kam Shah, Chief Financial Officer and director
Dr. Gregory Bailey, Chairman

Bulletins

04/01/2018

2018-0101 Notice of Distribution - Portage Biotech Inc. (PBT.U)

Le 4 janvier/January 2018

Portage Biotech Inc. has announced plans to distribute, as a stock dividend, a substantial part of the 6,341,500 common shares it holds in Biohaven Pharmaceutical Holding Company Ltd (BHVN:NYSE).

Advertisement

Publicité

Latest CSE News

Upcoming Events

12_10_OCannabiz_Website

O’Cannabiz

Monday, December 10, 2018 (All day) to Tuesday, December 11, 2018 (All day)
12_11_13th_MA_Forum_Website.jpg

13th M&A Forum

Tuesday, December 11, 2018 -
8:00am to 7:00pm
12_11_13th_MA_Forum_Website

Into the Future – Emerging Tech Conference

Friday, December 14, 2018 -
9:00am to 3:00pm